Triciribine

DRUG2 trials

Sponsors

Prescient Therapeutics, Ltd.

Conditions

Hematologic MalignanciesLeukemiaOvarian Cancer

Phase 1

Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies

CompletedNCT00642031

Prescient Therapeutics, Ltd.Hematologic Malignancies, Leukemia

Start: 2006-08-31End: 2012-10-31Updated: 2016-08-09

PTX-200 and Carboplatin in Ovarian Cancer

TerminatedNCT01690468

Prescient Therapeutics, Ltd.Ovarian Cancer

Start: 2014-09-30End: 2019-12-31Updated: 2020-09-24